2021 annual financial data
TransCode Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -6,151,135 USD and net income was -6,843,399 USD.
Operating cash flow was -5,266,885 USD.
Get free TransCode Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -6,151,135 USD
- Net income
- -6,843,399 USD
- Operating cash flow
- -5,266,885 USD